Molecular Diagnostics. Castle Medical LLC.

Similar documents
YOUR FIRST CHOICE FOR IN-OFFICE GENETIC TESTING

The future is. Personalized Medicine.

The PREDICT Program at Vanderbilt : Four Drug Gene Interactions and Counting

Introduction to Pharmacogenetics Competency

Introduction to Pharmacogenomics in Pharmacy Practice

Cytochrome P450 Genotype Panel

Clinical Applications in Pharmacogenomics/Genomic Medicine. Post-Course Survey

PERSONALIZED MEDICINE & ADVANCES IN DRUG METABOLISM

CE Activity Announcement

Introduction to Genetics and Pharmacogenomics

geneombio Technologies

Personalized Human Genome Sequencing

RESPONSE TO RFP - Title Page

Introduction to Pharmacogenomics

Personalized Medicine: Will There be a Right Time to Implement?

PHARMACOLOGY Vol. I - Pharmacogenomics and Pharmacogenetics - Andrew A Somogyi and Janet K Coller PHARMACOGENOMICS AND PHARMACOGENETICS

Activity 4.3.2: Hypercholesterolemia

Author Proof. Genelex Corporation COMPANY PROFILE

Guidance for Industry

Molecular Medicine and Cardiovascular Effects of Drugs

Si mon P t e ersen J ones

Pharmacogenomics

Guideline on key aspects for the use of pharmacogenomics in the pharmacovigilance of medicinal products

ejifcc: IFCC PROFESSIONAL SCIENTIFIC EXCHANGE PROGRAMME (PSEP) REPORT: CYP1A2 AND CYP3A4 GENE POLYMORPHISMS Paloma Oliver Sáez

Guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health

The role of genomics in the development of new and improved therapies

MRC-Holland MLPA. Description version 12; 16 March 2015

Trend in diagnostic biochip. Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital

Pharmacogenomics information in SmPC

The Wonderful World of Informatics

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Chapter. Scientific background

Corporate Medical Policy

Farmacogenomics: meerwaarde en plaats in de Klinische Biologie

FDA s Critical Path Initiative and Drug Development

Part II of IV: Precision Medicine and Pharmacogenomics. How pharmacogenomics is improving patient care

Genetic Components of Predicting Drug Adverse Reactions in the Confederated Salish & Kootenai Tribal Population

Systematic Review into the Role of Genomics in Profiling Overall Drug Performance and Variability

Gene therapy. Findings by Alert

Pharmacogenomics in Pain Management

Brain Tumour Australia Information FACT SHEET 22 Clinical Trials: Questions and Answers

Your story is unique. Diet & Exercise. Environment. Your health. Lifestyle. Genetics A PICTURE OF YOUR HEALTH

NIH Public Access Author Manuscript Clin Pharmacol Ther. Author manuscript; available in PMC 2013 April 29.

Investing in Discovery

ORDERING HEALTHCARE PROFESSIONAL. Nilesh Dharajiya, M.D Nexus Center Drive San Diego, CA US. Cardiovascular Health

AutoGenomics, Inc. COMPANY PROFILE. For reprint orders, please contact:

Student Sheet 1.1: KWL Chart

Corporate Medical Policy

impact on a trial design and labeling

6th Form Open Day 15th July 2015

Product Description SALSA MLPA probemix P128-D1 CYP450 To be used with the MLPA General Protocol.

Disclosure. Gaps in Knowledge, Competence, Performance, or Patient Outcomes 7/10/2018. Overview. Precision Medicine: Outlive Your Family History

CIE Biology A-level Topic 16: Inherited change

Chapter 15 THE HUMAN GENOME PROJECT AND GENOMICS

Integrating Genomics in Family Medicine

Guideline on key aspects for the use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products

January 11, Genetics with DNA.notebook. Genetics

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT

New Paradigms for Advancing Personalized Medicine

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego

TOWARDS INDIVIDUALIZED MEDICINE: INSIGHTS GAINED FROM GENOMIC STUDIES

Exome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome.

Biology 321 Start Reading Chapter 6 in text. Also look carefully again at: 10 th edition pg on polymorphisms

A A T A C G T G A G T G A G G C C T T A A

Lina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof

of heritable factor ). 1. The alternative versions of genes are called alleles. Chapter 9 Patterns of Inheritance

Corporate Medical Policy

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001

AS91159 Demonstrate understanding of gene expression

So, just exactly when will genetics revolutionise medicine? - Part 1

The Beery Twins Story and Sepiapterin Reductase

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association

Genetically Sequencing Healthy Babies Yielded Surprising Results

Introduc)on to Pharmacology and Pharmacogenomics. Roxana Daneshjou May 9, 2013

Icd code 10 use of low molecular weight heparin

General background text Pharmacogenetics Dihydropyrimidine dehydrogenase (DPD)

A / adenine and T / thymine and C / cytosine and G / guanine do not allow U / uracil 1

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.

iccnet CHSA Clinical Protocol - HEPARIN

Discrete vs continuous trait eye color and skin color in humans shows continuous variation as does fruit size in tomato culivars

What is Genetics? Genetics The study of how heredity information is passed from parents to offspring. The Modern Theory of Evolution =

Moving Medication to Market More Quickly

Pharmacogenomics Relating to Drug Evaluation

Single Nucleotide Variant Analysis. H3ABioNet May 14, 2014

David C. Whitcomb, MD, PhD and Philip E. Empey, PharmD, PhD

Explain why the scientists used the same restriction endonuclease enzymes on each DNA sample

Happy Monday! Have out: 15.1 Notes (due today) Pen or pencil. Upcoming: 15.1 Quiz on block day 15.2 Notes due Friday (2/1)

Pharmacogenetics VALIDATION OF GENE VARIANT TESTING IN PHARMACOGENETICS WITH SEQUENOM MASSARRAY AND PCR

Managing the Risks Associated with Anticoagulant Therapy. Steve McGlynn Specialist Principal Pharmacist (Cardiology) NHS Greater Glasgow and Clyde

Biomarkers and clinical trials. Patricia woo UCL

Pharmacogenetics in American Indian Populations

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2

CTS. Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges. Clinical and Translational Science

Personalized Medicine: What does it mean and why do we want to get there?

The ABC s of Pharmacogenomics and Pharmacogenetics. Guillaume Pare MD, M.Sc., FRCPc Research Fellow Harvard Medical School

About Clinical Trials: What They Can Mean For You?

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)

Nanthealth Patient Informed Consent

Transcription:

Molecular Diagnostics Castle Medical LLC.

What is DNA testing? Pharmacogenomics is a scientific disciple that deals with the influence of patient s genotype on drug response. Objective: to deliver the right drug for the right patient at the right time. Pharmacogenomics is a tool that enables a switch from the one size fits all approach to a personalized therapy approach.

What is DNA testing? MOTHER FATHER This test is based on DNA genotyping NOT Sequencing Two copies AKA alleles of each gene. Both normal alleles Wild type (normal). One normal one mutated allele Heterozygous. Both mutated alleles Homozygous.

Benefits of DNA testing? Patients Physicians Health insurance companies Improve therapeutic effects Minimize unpleasant side effects Results are interesting and last a lifetime Improve safety and efficacy of the therapy Improve patients compliance (fewer side effects) Improve patients confidence in therapy Permanent takeaway information improves satisfaction Right drug to right patient minimize monetary loss. Example: Plavix Cutting-edge tech and takeaway information attracts clients

General introduction 1. CORE DME Panel 2. Warfarin Panel 3. Chemo Panel 4. MTHFR Test * One tube is not sufficient to get enough DNA to perform multiple tests. Please provide one tube for each test.

Collection technique Improper collection leads to delays and rejections. Make sure to connect with people responsible for DNA collections! Follow Castle s written instructions over those on the packaging Nothing in the mouth for 30 minutes beforehand Soak up saliva from between cheek and gum avoid teeth 30+ seconds on each side of the mouth total of at least 1 minute of collection

CORE DME panel (extended) CYP2D6 CYP2C9 CYP2C19 CYP3A4 CYP3A5 Common drug metabolizing enzymes tested in the old CORE DME panel CYP2B6 COMT OPRM1 SLCO1B1 New genes added to the panel

CORE DME panel (extended) CYP enzymes CYP (normal) Inactive products Remove from the body Active drugs Active drugs CYP (defective) Inactive products Drugs accumulate in the body Adverse effects ***To view the list of drugs affected by CYPs please go to http://www.castlemedical.com/dna/dmg.pdf

CORE DME panel (extended) CYP enzymes CYP (normal) Active products Therapeutic effect Prodrugs (inactive) CYP (defective) Active products Therapeutic failure Prodrugs (inactive) ***To view the list of drugs affected by CYPs please go to http://www.castlemedical.com/dna/dmg.pdf

CORE DME panel (extended) SLCO1B1 SLCO1B1 (normal) Drugs Inactive products Liver SLCO1B1 (defective) Drugs accumulate in the blood Liver Drugs affected: Cholesterol lowering drugs Statins. Eg. Simvastatin.

CORE DME panel (extended) OPRM1 OPRM1 (normal) Normal pain relief Opioid drugs OPRM1 (defective) Less pain relief Opioid drugs

CORE DME panel (extended) COMT COMT (normal) maintains their balance in the brain Neurotransmitters i.e Dopamine, adrenaline, serotonin Regulate Behavior, emotions, wisdom, judgment COMT (defective) leads to abnormal levels of neurotransmitters Neurotransmitters i.e Dopamine, adrenaline, serotonin Psychiatric disorders

Vocabulary Enzyme A protein that helps carry out a chemical reaction. Genotype What we know about a person s DNA. Helps us make predictions about their health. Phenotype The way a person actually is. Phenotypes on our reports are predictions based on patients genetics.

Core DME Sample Report

Core DME: Recommendations

Core DME: Inducers and Inhibitors Some drugs and plants can speed up or slow down the action of drug metabolizing enzymes. They can do this by sticking to enzymes directly or by causing cells to make more or less of an enzyme. This is one of the causes of drug interactions like taking statins with grapefruit juice.

Warfarin panel Warfarin is an anticoagulant used in thromboembolic disease. Too much warfarin. Excessive bleeding. Possible death Good target level of warfarin Too little warfarin. Clot formation. Possible death *Due to different genetic makeup every individual has different capacity to respond towards warfarin

Warfarin panel VKORC1 CYP2C9 GGCX CYP4F2 CACNA1C Regulate warfarin response Castle s warfarin panel results Add in www.warfarindosing.org Right dose of warfarin based on patient s genetic makeup

Warfarin panel

Warfarin panel Warfarin panel

MTHFR test What is MTHFR? This enzyme plays a critical role in vitamin-b12 and folate metabolism. What are consequences of Genetic defect in MTHFR gene? Less efficient enzyme activity that can lead to elevated homocysteine (a potentially toxic amino acid) levels. What are consequences of high homocysteine levels? Increase risk of developing cardiovascular disorders, psychiatric disorders, cancer, osteoporosis and pregnancy complications.

MTHFR test MTHFR DNA test Ora Collect Buccal swab AND OR Homocysteine quantification Urine sample Blood sample *Before collecting urine/blood samples, fasting for at least 12 hours is recommended.

MTHFR test Target clinics Cardiology clinics- This test is specially relevant for people who have a personal or family history of premature cardiovascular disease or thrombosis. It may also be ordered when a close relative has MTHFR gene mutations. Maternity hospitals- Prospective mothers with a history of miscarriages are also advised to go for this test.

MTHFR test..

MTHFR test..

In the Future Expanded Core panel is validated and will replace the old panel in early September Sequencer is running but not validated for clinical tests will test BRCA1, BRCA2 and PALB2 Tests on the new Core panel came from your and clinics suggestions. Keep them coming!

Thanks for listening! Any questions?